Skip to main content

Table 3 Event rates of clinical outcomes

From: Sex difference in the prognostic role of body composition parameters in Taiwanese patients undergoing transcatheter aortic valve implantation

Variables

All

(n = 221)

Female

(n = 125)

Male

(n = 96)

Pa

Overall cumulative mortality

 All-cause

64 (56.5)

35 (44.3)

29 (63.7)

0.704

 Cardiovascular

22 (28.1)

14 (25.2)

8 (28.3)

0.561

One-year cumulative mortality

 All-cause

32 (15.5)

20 (17.2)

12 (13.3)

0.601

 Cardiovascular

12 (6.1)

7 (6.4)

5 (5.7)

0.762

30-day cumulative mortality

 All-cause

10 (4.1)

5 (4.0)

5 (5.2)

0.939

 Cardiovascular

6 (2.7)

3 (2.4)

3 (3.1)

0.781

30-day VARC-2 defined outcomes

 Stroke or transient ischemic attack

4 (2.0)

2 (1.7)

2 (2.3)

0.997

 Life threatening bleeding

7 (3.4)

2 (1.7)

5 (5.6)

0.212

 Acute kidney injury, stage 2 or 3

15 (7.1)

6 (5.0)

9 (9.9)

0.751

 Coronary artery obstruction

2 (1.0)

1 (0.9)

1 (1.1)

0.805

 Myocardial infarction

4 (2.0)

2 (1.7)

2 (2.3)

0.387

 Major vascular complications

5 (2.4)

0 (0)

5 (5.6)

0.953

 New pacemaker implantation

8 (3.9)

3 (2.5)

5 (5.6)

0.142

 Moderate to severe paravalvular leakage

5 (2.4)

3 (2.5)

2 (2.3)

0.825

 Valve-related dysfunction requiring repeat procedureb

1 (0.5)

1 (0.9)

0 (0)

0.978

  1. Data were presented as number of event (event rate). Event rate was estimated by life table method
  2. Abbreviation: VARC Valve Academic Research Consortium
  3. aComparison was performed with adjustment for propensity scores
  4. bRepeat procedure refers to balloon aortic valvuloplasty, transcatheter aortic valve implantation, or surgical aortic valve replacement